Development of monoclonal antibody therapeutics for alzheimer's disease
Background: In a previous review article in the Taiwanese Journal of Psychiatry (Takeda and Tagami: Taiwanese J. Psychiatry 2020; 34: 152-61), we gave the development status of drugs for Alzheimer's disease, presented a relatively pessimistic view, and highlighted the difficulties in their deve...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Taiwanese Journal of Psychiatry |
Subjects: | |
Online Access: | http://www.e-tjp.org/article.asp?issn=1028-3684;year=2022;volume=36;issue=4;spage=148;epage=156;aulast=Takeda |